ReviewMolecular pharmaceutics2022
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components.
Pardis Kazemian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
155 papers cite itlatest 60 shown
this paperpooled itcites it